Excessive apoptosis is implicated in contributing to a range of disease states including autoimmune disease and acute or chronic neurodegenerative conditions, stabilising the VDAC2–BAK interaction may be a potential therapeutic strategy for inhibiting apoptosis in such settings. This evidence concerns the gene VDAC2 and autoimmune disease.